脓毒症中的高渗性脱水:对初始液体管理的影响
这项韩国全国性倾向评分匹配队列研究分析了2019年9月至2021年12月期间20家三级或大学附属医院ICU收治的成人脓毒症或脓毒性休克患者,高渗性脱水定义为血清渗透压≥295 mOsm/L。在4,487例患者中2,605例(58.1%)存在高渗性脱水,匹配后1,537对分析显示高渗性脱水组30天死亡率29.9%高于非脱水组27.3%(调整OR 1.18;95%CI 1.00-1.39)。入ICU前液体管理>30 mL/kg与高渗性脱水组乳酸水平改善相关(P=0.009)且不增加SOFA评分(P=0.111);而在非脱水组,该液体策略与SOFA评分增加(P=0.034)和机械通气风险升高(P<0.001)相关,且未改善乳酸水平(P=0.388)。作者认为这些发现提示脓毒症管理中应根据脱水状态进行个体化液体管理。
要点
- 脓毒症诊断时血清渗透压≥295 mOsm/L定义的高渗性脱水在4,487例中占58.1%(2,605例),匹配后该组30天死亡率29.9% vs 非脱水组27.3%(调整OR 1.18;95%CI 1.00-1.39)。
- 入ICU前液体量>30 mL/kg在高渗性脱水组与乳酸水平改善相关(P=0.009),且不增加SOFA评分(P=0.111)。
- 在非脱水组,入ICU前液体量>30 mL/kg与SOFA评分增加(P=0.034)和机械通气风险升高(P<0.001)相关,且乳酸水平未改善(P=0.388)。
- 作者认为应根据脓毒症患者的脱水状态进行个体化初始液体管理。
适用人群与场景
- 韩国20家三级或大学附属医院ICU收治的成人脓毒症或脓毒性休克患者。
诊断标准与关键阈值
- 高渗性脱水定义为血清渗透压≥295 mOsm/L。
- 入ICU前液体管理>30 mL/kg定义为宽松液体管理。
处置流程与药物剂量
- 入ICU前液体量>30 mL/kg在高渗性脱水组与乳酸水平改善相关(P=0.009)且不增加SOFA评分(P=0.111)。
- 在非脱水组,入ICU前液体量>30 mL/kg与SOFA评分增加(P=0.034)和机械通气风险升高(P<0.001)相关,且乳酸水平未改善(P=0.388)。
研究设计与关键结果
- 研究类型:全国性倾向评分匹配队列研究,数据前瞻性收集于2019年9月至2021年12月,共4,487例患者,其中2,605例(58.1%)存在高渗性脱水。
- 匹配后分析1,537对,高渗性脱水组30天死亡率29.9% vs 非脱水组27.3%(调整OR 1.18;95%CI 1.00-1.39)。
- 使用限制性立方样条模型分析入ICU前液体量作为连续变量与临床结局的关系。
- 高渗性脱水组:入ICU前液体量>30 mL/kg与乳酸水平改善相关(P=0.009),SOFA评分无显著增加(P=0.111)。
- 非脱水组:入ICU前液体量>30 mL/kg与SOFA评分增加(P=0.034)和机械通气风险升高(P<0.001)相关,乳酸水平无显著改善(P=0.388)。
证据类型、等级与局限
- 证据类型:全国性倾向评分匹配队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现强调在脓毒症管理中应根据脱水状态进行个体化液体管理。
- 对于高渗性脱水(血清渗透压≥295 mOsm/L)的脓毒症患者,入ICU前液体量>30 mL/kg可能与乳酸水平改善相关而不增加SOFA评分。
- 对于非高渗性脱水的脓毒症患者,入ICU前液体量>30 mL/kg可能与SOFA评分增加和机械通气风险升高相关,且不改善乳酸水平。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Patients with sepsis are prone to hypovolemia which can lead to hyperosmolar dehydration and result in intracellular volume depletion. This study aimed to assess the effect of hyperosmolar dehydration on the clinical outcomes of patients with sepsis and its potential as an indicator of optimal initial fluid management.
DESIGN: A nationwide propensity score-matched cohort study analyzing data prospectively collected between September 2019 and December 2021.
SETTING: Twenty tertiary- or university-affiliated hospitals in South Korea.
PATIENTS: Adult patients with sepsis or septic shock admitted to the ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Hyperosmolar dehydration was defined as serum osmolarity greater than or equal to 295 mOsm/L. The primary outcome, 30-day mortality, was compared using logistic regression adjusted for key prognostic factors in a 1:1 propensity score-matched cohort. Restricted cubic-spline models were used to analyze the clinical outcomes using the pre-ICU fluid volume as a continuous variable. Of the 4,487 patients, 2,605 (58.1%) had hyperosmolar dehydration. After matching, 1,537 pairs were analyzed. The 30-day mortality was higher in the hyperosmolar dehydration group (29.9%) than in the non-dehydration group (27.3%) (adjusted odds ratio, 1.18; 95% CI, 1.00-1.39). Liberal fluid management (greater than30 mL/kg) before ICU admission was associated with improved lactate levels in the hyperosmolar dehydration group ( p = 0.009) without increasing sequential organ failure assessment score ( p = 0.111). Among patients without dehydration, liberal fluid management was associated with an increased Sequential Organ Failure Assessment score ( p = 0.034) and a higher risk for mechanical ventilation ( p < 0.001), and without improving lactate levels ( p = 0.388).
CONCLUSIONS: Hyperosmolar dehydration at the diagnosis of sepsis was associated with increased 30-day mortality. A liberal fluid management benefits patients with hyperosmolar dehydration by improving lactate levels without increasing sequential organ failure assessment score. These findings highlight the importance of individualized fluid management based on the dehydration status in sepsis management.
参考来源
- Lee KE, Lee J, Lee SM, et al. Hyperosmolar Dehydration in Sepsis: Implications for Initial Fluid Management. Crit Care Med. 2025. PMID: 41061135. doi:10.1097/CCM.0000000000006891
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。